IHS Chemical Week

Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients

Dr. Reddy’s API Site in Mexico Receives U.S. FDA Warning

2:42 AM MDT | June 17, 2011 | Deepti Ramesh

Pharmaceutical company Dr. Reddy’s Laboratories (Hyderabad, India) says that Industrias Quimicas Falcon de Mexico, its wholly owned manufacturing facility at Cuernavaca, Mexico has received a warning letter from the U.S. Food and Drug Administration (FDA). The facility produces intermediates and active pharmaceutical ingredients (API). An FDA inspection of the Cuernavaca facility in November 2010 identified certain deviations from current good manufacturing practice (cGMP) for the manufacture of APIs, the FDA says. Dr. Reddy’s says it responded to the...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week subscriber yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine a year in print or digital format
  • Real time news and analysis on chemweek.com 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now


contact us | about us | privacy policy | sitemap

ihsCopyright © IHS, Inc.All rights reserved.Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa